Phospho-tau on the other hand, is now considered a biomarker with molecular specificity for AD, reflecting neurofibrillary degeneration, and it is usually normal in other neurological diseases [92,93,97], including pure iNPH [37]. This evidence concerns the gene MAPT and Alzheimer disease.